A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...
LeadingAge urged the Centers for Medicare and Medicaid Services to step up its oversight of MA insurers’ use of AI.
10h
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
The Increasing Organ Transplant Access Model ("IOTA Model") introduces mandatory financial incentives and penalties for selected kidney ...
The Centers for Medicare & Medicaid Services (CMS) finalized significant updates to the Medicare 60-Day Rule, which governs ...
CMS said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated ...
As the demand for personalized and effective health care solutions grows, home health care providers are implementing more ...
Robert F. Kennedy Jr. said he would follow the Trump administration’s orders on prescription drug price negotiations, a ...
The FDA's move may change how doctors treat chronic kidney disease, which, according to Ozempic maker Novo Nordisk, affects around 37 million Americans and is one of the leading causes of death in the ...
The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback